Efficacy of modified bevacizumab-XELOX therapy in Japanese patients with stage IV recurrent or non-resectable colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of modified bevacizumab-XELOX therapy in Japanese patients with stage IV recurrent or non-resectable colorectal cancer

Published:2021-04 Issue:2 Volume:12 Page:527-534
ISSN:2078-6891
Container-title:Journal of Gastrointestinal Oncology
language:
Short-container-title:J Gastrointest Oncol

Author:

Yokoyama Daiki,Mukai Masaya,Uda Shuji,Kishima Kyouko,Koike Takuya,Hasegawa Sayuri,Izumi Hideki,Yamamoto Souichirou,Tajima Takayuki,Nomura Eiji,Makuuchi Hiroyasu

Publisher

AME Publishing Company

Subject

Gastroenterology,Oncology

Link

https://jgo.amegroups.com/article/download/50687/pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer;Journal of Gastrointestinal Oncology;2023-04

2. A 73-Year-Old Woman Treated for Rheumatoid Arthritis with Lower Rectal Carcinoma Who Underwent Abdominoperineal Resection, Lateral Regional Lymph Node Resection, and Partial Hepatectomy by Hand-Assisted Laparoscopic Surgery (HALS): A Case Report;American Journal of Case Reports;2022-06-04

3. Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety;Computational and Mathematical Methods in Medicine;2021-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP